Fish Toxin Stops Cancer Growth
Toxin may inhibit cell division in cancerous cells.
Toxin may inhibit cell division in cancerous cells.
University of Freiburg researchers have isolated a fish toxin that could bolster cancer treatments.
Afp18 is part of the Yersinia ruckeri genome, a pathogen family responsible for the redmouth disease in salmon and trout and the bubonic plague in humans.
The toxin Afp18 deactivates the protein RhoA. RhoA is responsible for many vital processes in human and fish. It has the ability to build up and break down actin filaments, which are necessary for cell division.
Dr. Thomas Jank and his team, led by Dr. Klaus Aktories, discovered that while this protein is important for cell life, it is also a key element in cancer development as well. With help from Dr. Daan von Aalten from the University of Dundee, the team used x-ray analysis to look at the protein on an atomic level, which showed that Rho-regulatory proteins are heavily involved in the growth of cancer.
Scientists injected this toxin into zebra fish embryos. Upon injection, cell division was blocked and the embryos did not develop. If this pathogen were to be controlled, it could stop cell division in cancerous cells.
Cancer itself is uncontrolled growth of cells, so a toxin that deactivates a protein responsible for cell growth could be critical in any cancer treatment. If select parts of this protein could be shut down, cancer may be stopped in its earliest stages of growth.
This study was published in Nature Communications.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Effectively Managing Immunizations in the Long-Term Care SettingSeptember 18th 2025
Creating a Culture of Quality in Fast-Melt Tablet DevelopmentSeptember 18th 2025
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
